Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T O'Neill

Showing results (21-30 of 381) with videos related to

Pageof 39
Sort By:
Controlled Clinical Trials|December 31, 1997
Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significanceR T O'Neill
American Journal of Epidemiology|July 1, 1984
Sample sizes for estimation of the odds ratio in unmatched case-control studiesR T O'Neill
Statistics in Medicine|May 15, 1995
Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonizationR T O'Neill
Clinical Trials (London, England)|March 30, 2013
Reflections on Professor Jerome Cornfield's contributions to the US Food and Drug AdministrationRobert T O'Neill
Health Facilities Management|May 13, 2016
Changes to building and fire codesJeffrey T O'Neill
Statistics in Medicine|October 21, 2003
Sam Greenhouse: his contributions as a consultant to the Food and Drug AdministrationRobert T O'Neill
Journal of Health Care Chaplaincy|December 10, 1991
Caring at the end of lifeM T O'Neill
Biometrical Journal. Biometrische Zeitschrift|September 16, 2006
FDA's critical path initiative: a perspective on contributions of biostatisticsR T O'Neill
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 1, 1996
Voice of the victims--the key to consensus and support for alcoholism researchJ T O'Neill
Bailliere'S Clinical Rheumatology|August 1, 1997
Can we prevent fractures?T O'Neill, S Papapoulos
Pageof 39

Showing results (21-30 of 381) with videos related to

Sort By:
Pageof 39
Controlled Clinical Trials|December 31, 1997
Secondary endpoints cannot be validly analyzed if the primary endpoint does not demonstrate clear statistical significanceR T O'Neill
American Journal of Epidemiology|July 1, 1984
Sample sizes for estimation of the odds ratio in unmatched case-control studiesR T O'Neill
Statistics in Medicine|May 15, 1995
Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonizationR T O'Neill
Clinical Trials (London, England)|March 30, 2013
Reflections on Professor Jerome Cornfield's contributions to the US Food and Drug AdministrationRobert T O'Neill
Health Facilities Management|May 13, 2016
Changes to building and fire codesJeffrey T O'Neill
Statistics in Medicine|October 21, 2003
Sam Greenhouse: his contributions as a consultant to the Food and Drug AdministrationRobert T O'Neill
Journal of Health Care Chaplaincy|December 10, 1991
Caring at the end of lifeM T O'Neill
Biometrical Journal. Biometrische Zeitschrift|September 16, 2006
FDA's critical path initiative: a perspective on contributions of biostatisticsR T O'Neill
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 1, 1996
Voice of the victims--the key to consensus and support for alcoholism researchJ T O'Neill
Bailliere'S Clinical Rheumatology|August 1, 1997
Can we prevent fractures?T O'Neill, S Papapoulos
Pageof 39